CEO Of ORMP Nadav Kidron On The Company's Covid-19 Oral Vaccine Developments

The CEO of Oramed Pharmaceuticals (ORMP), Nadav Kidron, says that the company is developing oral delivery solutions for drugs currently delivered via injection. It is also seeking to transform the treatment of diabetes through its proprietary lead candidate.

The Watch List

24 Mar 2021

ON AIR
7:00 am
Futures

Get Market Minute

Daily insights for every investor

FOLLOW US

CEO Of ORMP Nadav Kidron On The Company's Covid-19 Oral Vaccine Developments

The CEO of Oramed Pharmaceuticals (ORMP), Nadav Kidron, says that the company is developing oral delivery solutions for drugs currently delivered via injection. It is also seeking to transform the treatment of diabetes through its proprietary lead candidate.

The Watch List

24 Mar 2021

ON AIR
7:00 am
Futures

Get Market Minute

Daily insights for every investor

FOLLOW US